Psilocybin for Major Depressive Disorder
JAMA Author Interviews
Limitations, Side Effects, and Importance of Blinding in Psilocybin Study
Discussion on the limitations of a psilocybin study for major depressive disorder, including side effects, sample representativeness, blinding challenges, and the need for diverse participant ethnicity and racial makeup in future studies.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
